The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 332:193 January 19, 1995 Number 3
NextNext

More on Fluoroquinolone Antibiotics and Tendon Rupture

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: In his letter (Sept. 15 issue),1 Huston described bilateral rupture of the Achilles tendon in a patient treated with enoxacin and prednisone. Although no cases of tendon rupture were reported to the Food and Drug Administration (FDA) during premarketing clinical trials of fluoroquinolones currently on the market, the following information from the FDA's Postmarketing Spontaneous Reporting System does support the need for increased awareness of this adverse event.

As of October 1994, 25 cases of tendon rupture were reported, 22 of them occurring outside the United States. The patients whose ages were reported ranged from 33 to . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.